Eli Lilly: Leerink Partners raises target price to $1,316 from $1,309
LLY•Leerink Partners raised its target price for Eli Lilly to $1,316 from $1,309.
Related News
Intuitive Surgical target price raised to $475 from $450
ISRG•
Corebridge Financial target price raised to $40 from $38
CRBG•
Jefferies cuts Clearway Energy target price to $37 from $38
CWEN•
Shipments of foreign-branded phones in China fall 14.8% year over year in September, data shows
XLK•
Bond selloff revives debate about euro zone banks’ 'doom loop'
XLF•